Tumor targeting nanoparticle E7
            49-57
            -HSP110-RGD elicits potent anti-tumor immune response in a CD8-dependent manner in cervical cancer-bearing mouse model

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1080/21645515.2021.1933875

Tumor targeting nanoparticle E7 _49-57 -HSP110-RGD elicits potent anti-tumor immune response in a CD8-dependent manner in cervical cancer-bearing mouse model

Yue Zhang & Jun Tang et al. · 2021-07-16

Our previous research verified that HSP (heat shock protein) 110 could enhance the anti-tumor effect of HPV16 E7

Links

DOI PubMed

Journal

Human Vaccines & Immunotherapeutics

Authors

Yue Zhang, Faliang Ren, Bing Ni, Tao Jing, Jun Tang

Funding

National Natural Sciences Foundation of China Grant No. 81502728 and 81370212 Anhui Provincial Natural Science Foundation Grant no. 1408085MH149 Special Project for Enhancing Science and Technology Innovation Ability Grant No. 2019XQY13 Third Military Medical University Funding

Tumor targeting nanoparticle E7 49-57 -HSP110-RGD elicits potent anti-tumor immune response in a CD8-dependent manner in cervical cancer-bearing mouse model

Links

Journal

Authors

Funding

Tumor targeting nanoparticle E7 _49-57 -HSP110-RGD elicits potent anti-tumor immune response in a CD8-dependent manner in cervical cancer-bearing mouse model